Zobrazeno 1 - 10
of 3 188
pro vyhledávání: '"Torabi, F"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Torabi, F.1 (AUTHOR) fatemeh@ita.br, Carlson, B. V.1 (AUTHOR)
Publikováno v:
European Physical Journal A -- Hadrons & Nuclei. Aug2023, Vol. 59 Issue 8, p1-6. 6p.
Publikováno v:
In Ceramics International 1 March 2023 49(5):7105-7141
Autor:
Bailey GA; Neuroscience and Mental Health Research Institute, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ, UK., Rawlings A; Swansea University Medical School, Singleton Park, Swansea, UK., Torabi F; Swansea University Medical School, Singleton Park, Swansea, UK.; Health Data Research UK, Swansea, UK., Pickrell WO; Swansea University Medical School, Singleton Park, Swansea, UK.; Department of Neurology, Morriston Hospital, Swansea Bay University Health Board, Swansea, UK., Peall KJ; Neuroscience and Mental Health Research Institute, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ, UK. PeallKJ@cardiff.ac.uk.
Publikováno v:
Journal of neurology [J Neurol] 2024 Jun; Vol. 271 (6), pp. 3398-3408. Date of Electronic Publication: 2024 Mar 21.
Autor:
Ghodsi, O. N., Torabi, F.
Publikováno v:
Phys. Rev. C 93, 064611(2016)
To analyze the property of nuclear matter in the 16O+208Pb collision system, the internuclear potential of the fusion reaction is calculated by using the Skyrme forces associated with an extensive nuclear matter incompressibility K range in the semic
Externí odkaz:
http://arxiv.org/abs/1702.08418
Autor:
Bradley, D.T., Murphy, S., McWilliams, P., Arnold, S., Lavery, S., Murphy, J., de Lusignan, S., Hobbs, R., Tsang, R.S.M., Akbari, A., Torabi, F., Beggs, J., Chuter, A., Shi, T., Vasileiou, E., Robertson, C., Sheikh, A., Reid, H., O'Reilly, D.
Publikováno v:
In Public Health February 2022 203:110-115
Autor:
Keene S; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK; NIHR Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, UK. Electronic address: sjk98@cam.ac.uk., Abbasizanjani H; Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK., Torabi F; Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK., Knight R; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; MRC Integrative Epidemiology Unit, Bristol, UK; NIHR Applied Research Collaboration West, Bristol, UK; NIHR Bristol Biomedical Research Centre, Bristol, UK., Walker V; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; MRC Integrative Epidemiology Unit, Bristol, UK; Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Raffetti E; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden., Cezard G; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK., Ip S; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Cambridge Centre for AI in Medicine, UK., Sampri A; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK., Bolton T; British Heart Foundation Data Science Centre, Health Data Research UK, London, UK., Denholm R; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; NIHR Bristol Biomedical Research Centre, Bristol, UK; Health Data Research UK South-West, Bristol, UK., Khunti K; Diabetes Research Centre, University of Leicester, UK., Akbari A; Population Data Science, Swansea University Medical School, Faculty of Medicine, Health, and Life Science, Swansea University, Swansea, UK., Quint J; School of Public Health, Imperial College London, London, W12 0BZ, United Kingdom., Denaxas S; British Heart Foundation Data Science Centre, Health Data Research UK, London, UK; Institute of Health Informatics, University College London; University College London, Hospitals Biomedical Research Centre, University College London, UK., Sudlow C; British Heart Foundation Data Science Centre, Health Data Research UK, London, UK., Di Angelantonio E; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK; NIHR Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, UK; British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK; Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Hinxton, UK; Health Data Science Centre, Human Technopole, Milan, Italy., Sterne JAC; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; NIHR Bristol Biomedical Research Centre, Bristol, UK; Health Data Research UK South-West, Bristol, UK., Wood A; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK; NIHR Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, UK; British Heart Foundation Data Science Centre, Health Data Research UK, London, UK; British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK; Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Hinxton, UK; NIHR Cambridge Biomedical Research Centre, UK; Cambridge Centre for AI in Medicine, UK., Whiteley WN; British Heart Foundation Data Science Centre, Health Data Research UK, London, UK; Centre for Clinical Brain Sciences, University of Edinburgh, UK.
Publikováno v:
Thrombosis research [Thromb Res] 2025 Jan; Vol. 245, pp. 109213. Date of Electronic Publication: 2024 Nov 19.
Autor:
Li R; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. rli11@mdanderson.org.; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. rli11@mdanderson.org.; MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. rli11@mdanderson.org., Strobl J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Poyner EFM; Biosciences Institute, Newcastle University, Newcastle, UK.; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Balbaa A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Torabi F; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Mazin PV; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Chipampe NJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Stephenson E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Ramírez-Suástegi C; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Shanmugiah VBM; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Gardner L; Biosciences Institute, Newcastle University, Newcastle, UK.; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Olabi B; Biosciences Institute, Newcastle University, Newcastle, UK.; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Coulthard R; NovoPath, Department of Cellular Pathology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Botting RA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Zila N; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Section Biomedical Science, University of Applied Sciences FH Campus Wien, Vienna, Austria., Prigmore E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Gopee NH; Biosciences Institute, Newcastle University, Newcastle, UK.; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Chroscik MA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Kritikaki E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Engelbert J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Goh I; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Chan HM; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Johnson HF; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Ellis J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Rowe V; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Tun W; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Reynolds G; Biosciences Institute, Newcastle University, Newcastle, UK.; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA., Yang D; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Foster AR; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Gambardella L; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Winheim E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Admane C; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Rumney B; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Steele L; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Jardine L; Biosciences Institute, Newcastle University, Newcastle, UK., Nenonen J; Division of Dermatology, Department of Medicine, Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden., Pickard K; Biosciences Institute, Newcastle University, Newcastle, UK., Lumley J; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Hampton P; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Hu S; Biomedical Pioneering Innovation Center and School of Life Sciences, Peking University, Beijing, China., Liu F; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China., Liu X; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China., Horsfall D; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Basurto-Lozada D; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Grimble L; Biosciences Institute, Newcastle University, Newcastle, UK., Bacon CM; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Weatherhead SC; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Brauner H; Division of Dermatology, Department of Medicine, Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Dermatology, Karolinska University Hospital, Stockholm, Sweden., Wang Y; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China., Bai F; Biomedical Pioneering Innovation Center and School of Life Sciences, Peking University, Beijing, China., Reynolds NJ; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Allen JE; Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Jonak C; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Brunner PM; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Teichmann SA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. st9@sanger.ac.uk.; Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. st9@sanger.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. st9@sanger.ac.uk., Haniffa M; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. mh32@sanger.ac.uk.; Biosciences Institute, Newcastle University, Newcastle, UK. mh32@sanger.ac.uk.; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. mh32@sanger.ac.uk.
Publikováno v:
Nature immunology [Nat Immunol] 2024 Dec 02. Date of Electronic Publication: 2024 Dec 02.
Autor:
Owen RK; Population Data Science, Swansea University Medical School, Swansea University, Swansea, United Kingdom., van Oppen JD; Centre for Urgent and Emergency Care Research (CURE), University of Sheffield, Sheffield, United Kingdom., Lyons J; Population Data Science, Swansea University Medical School, Swansea University, Swansea, United Kingdom., Akbari A; Population Data Science, Swansea University Medical School, Swansea University, Swansea, United Kingdom., Davies G; Population Data Science, Swansea University Medical School, Swansea University, Swansea, United Kingdom., Torabi F; Population Data Science, Swansea University Medical School, Swansea University, Swansea, United Kingdom., Abrams KR; Department of Statistics & Warwick Medical School (WMS), University of Warwick, Coventry, United Kingdom., Lyons RA; Population Data Science, Swansea University Medical School, Swansea University, Swansea, United Kingdom.
Publikováno v:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Dec; Vol. 29 (50).
Autor:
Li R; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. rli11@mdanderson.org.; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. rli11@mdanderson.org.; MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. rli11@mdanderson.org., Strobl J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Poyner EFM; Biosciences Institute, Newcastle University, Newcastle, UK.; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Balbaa A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Torabi F; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Mazin PV; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Chipampe NJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Stephenson E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Ramírez-Suástegi C; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Shanmugiah VBM; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Gardner L; Biosciences Institute, Newcastle University, Newcastle, UK.; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Olabi B; Biosciences Institute, Newcastle University, Newcastle, UK.; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Coulthard R; NovoPath, Department of Cellular Pathology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Botting RA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Zila N; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Section Biomedical Science, University of Applied Sciences FH Campus Wien, Vienna, Austria., Prigmore E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Gopee NH; Biosciences Institute, Newcastle University, Newcastle, UK.; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Chroscik MA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Kritikaki E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Engelbert J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Goh I; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Chan HM; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Johnson HF; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Ellis J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Rowe V; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Tun W; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Reynolds G; Biosciences Institute, Newcastle University, Newcastle, UK.; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA., Yang D; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Foster AR; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Gambardella L; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Winheim E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Admane C; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Rumney B; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Steele L; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Jardine L; Biosciences Institute, Newcastle University, Newcastle, UK., Nenonen J; Division of Dermatology, Department of Medicine, Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden., Pickard K; Biosciences Institute, Newcastle University, Newcastle, UK., Lumley J; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Hampton P; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Hu S; Biomedical Pioneering Innovation Center and School of Life Sciences, Peking University, Beijing, China., Liu F; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China., Liu X; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China., Horsfall D; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Basurto-Lozada D; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Biosciences Institute, Newcastle University, Newcastle, UK., Grimble L; Biosciences Institute, Newcastle University, Newcastle, UK., Bacon CM; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Weatherhead SC; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Brauner H; Division of Dermatology, Department of Medicine, Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Dermatology, Karolinska University Hospital, Stockholm, Sweden., Wang Y; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China., Bai F; Biomedical Pioneering Innovation Center and School of Life Sciences, Peking University, Beijing, China., Reynolds NJ; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Allen JE; Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Jonak C; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Brunner PM; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Teichmann SA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. st9@sanger.ac.uk.; Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. st9@sanger.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. st9@sanger.ac.uk., Haniffa M; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. mh32@sanger.ac.uk.; Biosciences Institute, Newcastle University, Newcastle, UK. mh32@sanger.ac.uk.; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle, Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. mh32@sanger.ac.uk.
Publikováno v:
Nature immunology [Nat Immunol] 2024 Dec; Vol. 25 (12), pp. 2320-2330. Date of Electronic Publication: 2024 Nov 18.